Hansen Pharmaceuticals: Net profit in the first quarter of 2025 decreased by 80.68% year-on-year.

Hansen Pharmaceuticals announced that in the first quarter of 2025, its operating income was 269 million yuan, an increase of 6.00% year-on-year. Net profit was 11.2572 million yuan, a decrease of 80.68% year-on-year.